Monitorización de la ocurrencia de extrasístoles ventriculares relacionadas con la infusión de antraciclinas como herramienta para la Enfermería

the cancer is responsible for 12% of all causes of death in the world, more than 7 million people die annually of the disease. the forms of treatment include surgery, radiotherapy and chemotherapy combined or not. among the chemotherapy used, the anthracyclines, in particular are included doxorubicin among the most cytotoxic agents used to treat acute leukemia, linfomas hodgkin e n？o hodgkin, than of breast cancer. the serious myelosuppression and the cardiac toxicity are the two major adverse reactions caused by antraciclinas. the occurrence of signs of cardiotoxicity in particular the extra-ventricular sistoles (evs), is the object and reasons of this study, whose objectives were comparing the occurrence of extra-ventricular systole in the immediate pre and post per immediate during treatment with anthracycline and establish a correlation between time of treatment and the occurrence of esv. this is an uncontrolled clinical trial, before, during and after a quantitative treatment. the sample of convenience consisted of 30 patients undergoing treatment with doxorubicin chemotherapy at the clinic of the university hospital (uh). it examined the number of evs, in pre, and post per infusion of patients who underwent anthracycline infusion of the chemotherapy outpatient clinic of university hospital. the results show that in pre-per pre-and post infusion, there were no statistically significant differences (p> 0,05), by parametric methods is not as parametric. it was concluded that the sample analysed the infusion of doxorubicin can be performed safely by nurse.